Tranding
Hap2py Launches in Thailand, Uniting Profit with Purpose
Abracon Names Brian Holt Vice President of Global Sales
Possibilities and Opportunities: Seminar held in Hong Kong about ETF Connect in China Allocation
enreap becomes an official Atlassian Specialized Partner in ITSM
China's Miao embroidery dresses shine at Milan Fashion Week
2024-12-30 02:08:26

CUSMail

Biotechnology

CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers
Health/ 2023-07-22
CARsgen Therapeutics Receives Orphan Med...

SHANGHAI,March 1,2021-- CARsgen Therapeutics Holdings Limited,a clinical-stage biopharmaceutical company,today announced that the European C...

Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant
Health/ 2023-07-22
Merck Builds on Leadership in Head and N...

- Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated loca...

Corporate / 2023-07-23
China Biologic Announces Shareholders' Appr...
Corporate / 2023-07-23
INOVIO Announces Positive Results from REVEAL 1,...
Health / 2023-07-22
CMAB Biopharma Congratulates QureBio on FDA Clea...
Corporate / 2023-07-23
Kazia Licenses Cantrixil, a Clinical-stage, Firs...
Corporate / 2023-07-23
Cipla receives final approval for generic versio...
Health / 2023-07-22
Merck and GPHL Collaborate on Business Innovatio...
Corporate / 2023-07-23
Global Cord Blood Corporation Announces Receipt ...
Health / 2023-07-22
Sunquest Lauded by Frost & Sullivan for Driv...
Health / 2023-07-22
Biocytogen announces acquisition of a third Beac...
Corporate / 2023-07-23
Alterity to present at the 7th International Con...
Health / 2023-07-22
Debiopharm And Genome & Company Join Forces ...
Corporate / 2023-07-23
Antengene (6996.HK) Selected as a Constituent St...
Corporate / 2023-07-23
Innovent Announces First Patient Outside China D...
Corporate / 2023-07-23
Antengene (6996.HK) Selected as a Constituent St...
Health / 2023-07-22
Sciwind's Investigational New Drug Approved...
Health / 2023-07-22
Zymergen Appoints Global Finance Expert Enakshi ...
Health / 2023-07-22
VLP BioTech, Inc. Announces an Immunotherapy Des...
Corporate / 2023-07-23
Genome & Company and Debiopharm Join Forces ...

Follow Us

12,345 Fans 12,345 Followers
12,345 Connects 12,345 Followers
12,345 Subscribers 12,345 Followers

Newsletter

Join us to get the latest news.

Received instesting content ASAP

Tranding

News / 2023-11-05
Hap2py Launches in Thailand, Uniting Profit with Purpose
News / 2023-11-05
Abracon Names Brian Holt Vice President of Global Sales
News / 2023-11-05
Possibilities and Opportunities: Seminar held in Hong Ko
News / 2023-11-05
enreap becomes an official Atlassian Specialized Partner
Exhibition / 2023-09-26
China's Miao embroidery dresses shine at Milan Fash

Tags

Computer/ElectronicsBanking/Financial ServiceHealth Care/HospitalTelecommunicationsComputer SoftwareMedical/PharmaceuticalsEntertainmentRetailTransportationEnvironmental Products & Services

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

Categories

NewsBusinessGeneral BusinessFinancial ServicesExhibitionReal Estate and FurnitureAdvertising, Marketing MediaPolicy & Public InterestTechnologyAuto & TransportationBusiness TechnologyConsumer TechnologyEnergyEnvironmentTelecommunicationsHeavy Industry & ManufacturingCorporateEntertainmentLifeStyleTravelFoodsHealthSportsEducation

Tags

Fitness/WellnessArtificial IntelligenceSupply Chain/LogisticsGeneral ManufacturingCloud Computing / Internet of ThingsEnvironmentVoIPMutual FundsCannabisInfectious Disease ControlOTC/SmallCap IRWPublic InterestTobaccoBridal ServicesLegal Services

Quick Links

AboutAdvertisePrivacy & policyTerms & conditionsContact

© CUSMAIL. All Rights Reserved. Operate by Paid Release